Research Articles | Page 6 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Phase II study of the clinical efficacy and safety of tosedostat in patients with myelodysplastic syndromes (MDS) after failure of hypomethylating agent-based therapy Oct 2020 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
Consensus minimum hemoglobin level above which patients with myelodysplastic syndromes can safely forgo transfusions Jul 2020 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
Raising the bar for lower-risk myelodysplastic syndromes Apr 2023 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
Cardiac and genetic predictors of cardiovascular risk in patients with myelodysplastic syndromes May 2019 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes May 2019 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience Nov 2020 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
Wide Variation in Use and Interpretation of Gene Mutation Profiling Panels Among Health Care Providers of Patients With Myelodysplastic Syndromes: Results of a Large Web-Based Survey Jun 2020 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
RBC transfusion independence among lower risk MDS patients receiving hypomethylating agents: a population-level analysis Jun 2019 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant? Nov 2020 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
Clinical outcomes and characteristics of patients with TP53-mutated acute myeloid leukemia or myelodysplastic syndromes: a single center experience Sep 2020 Leukemia & Lymphoma Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)